Capital International Investors Organon & Co. Transaction History

Capital International Investors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $4.67 Million - $6.04 Million	-153,489 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $15.3 Million - $19.9 Million	-534,909 Reduced 77.7%	153,489 $4.67 Million
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $41.3 Million - $51.4 Million	-1,441,943 Reduced 67.69%	688,398 $22.6 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $60.6 Million - $81 Million	2,130,341 New	2,130,341 $64.5 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.